S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
The gold catalyst we’ve waited for (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden’s Big Lie… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden’s Big Lie… (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
The gold catalyst we’ve waited for (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden’s Big Lie… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden’s Big Lie… (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
The gold catalyst we’ve waited for (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden’s Big Lie… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden’s Big Lie… (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
The gold catalyst we’ve waited for (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden’s Big Lie… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden’s Big Lie… (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?

Coca-Cola Europacific Partners - CCEP Earnings Date, Estimates & Call Transcripts

$57.07
-0.22 (-0.38%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$56.86
$57.45
50-Day Range
$54.05
$57.29
52-Week Range
$41.80
$57.63
Volume
735,590 shs
Average Volume
1.18 million shs
Market Capitalization
$26.07 billion
P/E Ratio
N/A
Dividend Yield
3.89%
Price Target
$61.79

Coca-Cola Europacific Partners Analyst Forecasts

Current Year EPS Consensus Estimate: $3.78 EPS
Next Year EPS Consensus Estimate: $4.08 EPS

CCEP Earnings Date and Information

Coca-Cola Europacific Partners has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 18th, 2023 based off prior year's report dates.

Coca-Cola Europacific Partners Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/18/2023
(Estimated)
        
2/14/201912/31/2018$0.62$0.54($0.08)$0.92$2.82 billion$2.79 billion  
10/25/2018Q3 2018$0.87$0.88+$0.01$0.91$3.69 billion$3.82 billion
8/9/2018Q2 2018$0.79$0.80+$0.01$0.88$3.63 billion$3.65 billion
8/9/2018Q2 2018$0.65$0.67+$0.02$0.88$3.07 billion$3.06 billion
4/26/2018Q1 2018$0.39$0.41+$0.02$0.51$3.02 billion$2.92 billion
4/26/2018Q1 2018$0.32$0.33+$0.01$0.51$2.45 billion$2.38 billion
2/15/2018Q4 2017$0.55$0.58+$0.03$1.31$3.06 billion$3.14 billion
2/15/2018Q4 2017$0.55$0.58+$0.03$1.31$2.58 billion$2.66 billion  
11/7/2017Q3 2017$0.80$0.80$0.87$3.53 billion$3.48 billion
11/7/2017Q3 2017$0.80$0.68($0.12)$0.87$2.99 billion$2.96 billion
8/10/2017Q2 2017$0.64$0.74+$0.10$0.81$3.28 billion$3.36 billion
8/10/2017Q2 2017$0.64$0.74+$0.10$0.81$2.77 billion$3.05 billion
5/4/2017Q1 2017$0.31$0.33+$0.02$0.34$2.52 billion$2.54 billion
5/4/20173/31/2017$0.31$0.33+$0.02$0.34$2.52 billion$2.54 billion
3/21/2017Q4 2016$0.46$0.46$0.89$2.81 billion$2.78 billion
3/21/201712/31/2016$0.46$0.46$0.89$2.54 billion$2.58 billion
11/10/2016Q3 2016$0.72$0.74+$0.02$0.73$3.27 billion$3.33 billion
11/10/2016Q316$0.72$0.74+$0.02$0.73$3.18 billion$2.99 billion
9/22/2016Q2 2016$0.73$0.63($0.10)$0.75$3.38 billion$2.45 billion
9/22/2016Q2$0.74$0.63($0.11)$0.75$3.03 billion$2.87 billion  
4/28/2016Q1 2016$0.40$0.41+$0.01$0.53$1.53 billion$1.52 billion
4/28/2016Q116$0.40$0.41+$0.01$0.53$1.55 billion$1.50 billion  
2/11/2016Q4 2015$0.51$0.53+$0.02$0.39$1.65 billion$1.63 billion
2/11/2016Q415$0.51$0.53+$0.02$0.39$1.64 billion$1.63 billion  
10/29/2015Q3 2015$0.81$0.84+$0.03$0.96$1.89 billion$1.82 billion
10/29/2015Q315$0.81$0.84+$0.03$0.96$1.88 billion$1.80 billion  
7/30/2015Q2 2015$0.76$0.79+$0.03$0.83$1.89 billion$1.93 billion
7/30/2015Q215$0.76$0.79+$0.03$0.83$1.90 billion$1.90 billion  
4/30/2015Q1 2015$0.41$0.42+$0.01$0.44$1.68 billion$1.63 billion
4/30/2015Q115$0.41$0.42+$0.01$0.44$1.68 billion$1.63 billion  
2/12/2015Q4 2014$0.56$0.58+$0.02$0.70$1.92 billion$1.93 billion
2/12/2015Q414$0.56$0.58+$0.02$0.70$1.94 billion$1.93 billion  
10/23/2014Q3 2014$0.88$0.92+$0.04$0.88$2.22 billion$2.14 billion
10/23/2014Q314$0.88$0.92+$0.04$0.88$2.29 million$2.10 billion  
7/24/2014Q2 2014$0.88$0.90+$0.02$1.02$2.35 billion$2.33 billion
7/24/2014Q214$0.88$0.90+$0.02$1.02$2.34 billion$2.33 billion  
4/24/2014Q1 2014$0.44$0.46+$0.02$0.48$1.93 billion$1.87 billion
4/24/2014Q1$0.44$0.46+$0.02$0.48$1.93 million$1.87 million  
2/5/2014Q4 2013$0.52$0.54+$0.02$0.57$2.05 billion$2.03 billion
2/5/2014Q4 2013$0.52$0.54+$0.02$0.57$2.03 billion$2.03 billion  
10/24/2013Q3 2013$0.80$0.82+$0.02$0.57$2.17 billion$2.17 billion
10/24/2013Q3 2013$0.80$0.82+$0.02$0.57$2.14 billion$2.17 billion  
7/25/2013Q2 2013$0.75$0.77+$0.02$0.88$2.21 billion$2.16 billion
7/25/2013Q2 2013$0.75$0.77+$0.02$0.88$2.22 billion$2.16 billion  
4/25/2013Q1 2013$0.38$0.39+$0.01$0.57$1.91 billion$1.85 billion
4/25/2013Q1 2013$0.38$0.39+$0.01$0.57$1.92 billion$1.90 billion  
2/7/2013Q4 2012$0.44$0.34($0.10)$1.92 billion$1.92 billion  
10/25/2012$0.69$0.71+$0.02  
7/23/2012$0.73$0.73
4/26/2012$0.33$0.36+$0.03
2/9/2012$0.36$0.36  
10/27/2011$0.70$0.72+$0.02
7/28/2011$0.74$0.74
4/28/2011$0.33$0.33
2/11/2011$0.28$0.28
10/28/2010Q3 2010$0.54$0.60+$0.06$0.59
7/28/2010Q2 2010$0.69$0.79+$0.10$0.89
4/27/2010Q1 2010$0.22$0.27+$0.05$0.33
2/10/2010Q4 2009$0.21$0.22+$0.01$0.22
10/28/2009Q3 2009$0.46$0.51+$0.05$0.52
7/29/2009Q2 2009$0.51$0.67+$0.16$0.70
4/28/2009Q1 2009$0.05$0.20+$0.15$0.27
2/11/2009Q4 2008$0.19$0.22+$0.03$3.43
10/23/2008Q3 2008$0.46$0.46$0.48
7/17/2008Q2 2008$0.54$0.56+$0.02$7.64
4/24/2008Q1 2008$0.10$0.08($0.02)$0.14
2/12/2008Q4 2007$0.27$0.29+$0.02$0.26












Coca-Cola Europacific Partners Earnings - Frequently Asked Questions

When is Coca-Cola Europacific Partners's earnings date?

Coca-Cola Europacific Partners has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 18th, 2023 based off last year's report dates. Learn more on CCEP's earnings history.

How much revenue does Coca-Cola Europacific Partners generate each year?

Coca-Cola Europacific Partners (NYSE:CCEP) has a recorded annual revenue of $18.25 billion.

How much profit does Coca-Cola Europacific Partners generate each year?

Coca-Cola Europacific Partners (NYSE:CCEP) has a recorded net income of $1.59 billion. CCEP has generated $0.00 earnings per share over the last four quarters.

What is Coca-Cola Europacific Partners's price-to-earnings ratio?

Coca-Cola Europacific Partners (NYSE:CCEP) has a forward price-to-earnings ratio of 15.10. The price/earnings-to-growth ratio is 2.3.

What is Coca-Cola Europacific Partners's EPS forecast for next year?

Coca-Cola Europacific Partners's earnings are expected to grow from $3.78 per share to $4.08 per share in the next year, which is a 7.94% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:CCEP) was last updated on 3/29/2023 by MarketBeat.com Staff